Epidermal growth factor receptor targeted therapy by ZD 1839 (Iressa) in patients with brain metastases from non-small cell lung cancer (NSCLC)
To access this article, please choose from the options below
PII: S0169-5002(03)00189-2
doi:10.1016/S0169-5002(03)00189-2
© 2003 Elsevier Science Ireland Ltd. All rights reserved.
